Litcius/Paper detail

The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: A comprehensive review

Sarah Ahmed, K.L. Chen, Victoria P. Werth

2020Seminars in Arthritis and Rheumatism27 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDermatomyositisClinical trialQuality of life (healthcare)DiseasePhysical therapyPatient-reported outcomeSeverity of illnessInternal medicineIntensive care medicineNursingInflammatory Myopathies and DermatomyositisRheumatoid Arthritis Research and TherapiesDermatology and Skin Diseases
The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: A comprehensive review | Litcius